by bmi_wpadmin | Jul 22, 2022 | BayMedica, Cannabinoids
In the cannabis industry, it’s hard to improve the plant. Nature has crafted a nearly perfect specimen; hearty and multi-purpose, capable of growing around the world and providing fibers, food, and medicine. When a plant can have so many purposes, it’s hard to...
by bmi_wpadmin | Jul 14, 2022 | BayMedica
Jerry P. Griffin, VP of Sales and Marketing at BayMedica, InMed’s subsidiary, is interviewed by Shadd Dales of The Dales Report to talk about the recent B2B sales launch of rare cannabinoid #tetrahydrocannabivarin #d9 #THCV into the health and wellness sector....
Recent Comments